BioCentury | Dec 19, 2020
Management Tracks

RNA pioneer Crooke readies to look beyond Ionis

Another member of biotech’s founding generation is preparing to move on. Ionis Executive Chairman Stanley Crooke, who founded Ionis as Isis in 1989 and over the next three decades was unyielding in his decidation to...
BioCentury | Dec 4, 2020
Product Development

Continuing the conversation with Henri: Termeer Square dedicated

...Editor It seemed to many people when Henri Termeer...
...to continuing conversations. Its cornerstone is the Henri Termeer...
...sciences companies and their leaders. Steve Usdin Genzyme Sanofi Alnylam Pharmaceuticals Inc. Henri Termeer Termeer...
BioCentury | Oct 2, 2020
Deals

From Termeer to scuttled Allergan deal, Lysosomal’s winding road continues with Bial takeout

...Bob Carpenter, Peter Wirth and the late Henri Termeer...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...another $15 million earlier this year from a convertible note. Its investors included the late Henri Termeer...
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...by Advent Life Sciences, with participation from Belinda Termeer, the widow of former Genzyme CEO Henri Termeer...
BioCentury | Apr 18, 2019
Finance

Arranging Arrakis' syndicate

...of that round's investors, including Advent Life Sciences, Osage University Partners and the estate of Henri Termeer...
BioCentury | Apr 18, 2019
Financial News

RNA-targeting small molecule company Arrakis raises $75M series B

...Advent Life Sciences, Pfizer Ventures, Celgene Corp. (NASDAQ:CELG), Osage University Partners and the estate of Henri Termeer...
BioCentury | Apr 2, 2019
Financial News

Ocular oncology play Aura raises $40M D round

...Columbus Venture Partners, LI-COR Biosciences and individual investors, including the estate of orphan drug pioneer Henri Termeer...
BioCentury | Nov 2, 2018
Politics, Policy & Law

Clear and present danger

...hostility and hurdles they will encounter. If the next young, ambitious and talented person like Henri Termeer...
BioCentury | Feb 28, 2018
Company News

Termeer celebrated on Rare Disease Day

...Biotech pioneer Henri Termeer, who passed away in 2017, was honored Wednesday at a ceremony in Cambridge...
...bringing hope to patients and families around the world (see BioCentury, May 19, 2017) . Steve Usdin Genzyme Sanofi Henri Termeer...
Items per page:
1 - 10 of 111
BioCentury | Dec 19, 2020
Management Tracks

RNA pioneer Crooke readies to look beyond Ionis

Another member of biotech’s founding generation is preparing to move on. Ionis Executive Chairman Stanley Crooke, who founded Ionis as Isis in 1989 and over the next three decades was unyielding in his decidation to...
BioCentury | Dec 4, 2020
Product Development

Continuing the conversation with Henri: Termeer Square dedicated

...Editor It seemed to many people when Henri Termeer...
...to continuing conversations. Its cornerstone is the Henri Termeer...
...sciences companies and their leaders. Steve Usdin Genzyme Sanofi Alnylam Pharmaceuticals Inc. Henri Termeer Termeer...
BioCentury | Oct 2, 2020
Deals

From Termeer to scuttled Allergan deal, Lysosomal’s winding road continues with Bial takeout

...Bob Carpenter, Peter Wirth and the late Henri Termeer...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...another $15 million earlier this year from a convertible note. Its investors included the late Henri Termeer...
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...by Advent Life Sciences, with participation from Belinda Termeer, the widow of former Genzyme CEO Henri Termeer...
BioCentury | Apr 18, 2019
Finance

Arranging Arrakis' syndicate

...of that round's investors, including Advent Life Sciences, Osage University Partners and the estate of Henri Termeer...
BioCentury | Apr 18, 2019
Financial News

RNA-targeting small molecule company Arrakis raises $75M series B

...Advent Life Sciences, Pfizer Ventures, Celgene Corp. (NASDAQ:CELG), Osage University Partners and the estate of Henri Termeer...
BioCentury | Apr 2, 2019
Financial News

Ocular oncology play Aura raises $40M D round

...Columbus Venture Partners, LI-COR Biosciences and individual investors, including the estate of orphan drug pioneer Henri Termeer...
BioCentury | Nov 2, 2018
Politics, Policy & Law

Clear and present danger

...hostility and hurdles they will encounter. If the next young, ambitious and talented person like Henri Termeer...
BioCentury | Feb 28, 2018
Company News

Termeer celebrated on Rare Disease Day

...Biotech pioneer Henri Termeer, who passed away in 2017, was honored Wednesday at a ceremony in Cambridge...
...bringing hope to patients and families around the world (see BioCentury, May 19, 2017) . Steve Usdin Genzyme Sanofi Henri Termeer...
Items per page:
1 - 10 of 111